The ISH population (n=1014) was 61.4% female, 10.5% black with a mean age of 67.3 years (Table 1). Of the 964 patients evaluated for efficacy at week 8, 634 patients (66%) received candesartan ...
This was a phase III, randomized, double-blind, parallel-group study comparing the efficacy and safety of azilsartan and candesartan cilexetil (candesartan) in Japanese patients with grade I or II ...
We investigated whether 10 mg per day of azilsartan, one-half of the normal dosage, would be non-inferior to 8 mg per day of candesartan cilexetil for controlling blood pressure in Japanese patients ...
Description: The goal of the trial was to evaluate the effect of treatment with the angiotensin II receptor blocker (ARB) candesartan cilexetil on intimal hyperplasia after coronary stent implantation ...
NEW DELHI: Zydus Cadila has received final approval from the US health regulator to market candesartan cilexetil tablets used for treatment of hypertension. The company has received final nod from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback